Abstract:Rheumatoid arthritis (RA) is a multifactorial disease and requires interaction between genetic and environmental factors for predisposition. The presence of bacterial DNA of the gut residing commensals in synovium as well as dysbiosis of certain commensal bacteria in faecal samples of RA patients as compared to controls suggest a significant role of the gut flora in pathogenesis of RA. The gut commensals are involved in host immune development and function suggesting they might be critical epigenetic factors modifying autoimmune diseases like RA. This raises the question if gut-derived commensal can be exploited to generate a biomarker profile along with genetic factors to define individuals at risk. Genomic wide association studies have confirmed the HLA (human leukocyte antigen) class II genes as the strongest risk factor for predisposition to RA. HLA-DQ8 and DRB1FNx010401 molecules predispose to develop arthritis while DRB1FNx010402 provides protection. Interaction between host genetic factors like major histocompatibility complex (MHC) and gut microbiota and its impact on the development of RA is difficult to study in humans due to high variability in the genetic factors and diet. Animal models provide a means to study the molecular basis of pathogenesis thereby providing a basis for developing therapeutic strategies. Using transgenic mice expressing RA-associated and resistant HLA genes, we have developed a collagen-induced arthritis (CIA) model that shares similarities with human disease in sex-bias, autoantibody profile and phenotype. Studies in transgenic mice suggest that arthritis-susceptibility may be associated with dysbiosis in the gut microbiome. Studies in animal models underscore the impact of the gut flora in extra-intestinal diseases. Exploring the role of gut microbes will significantly advance our understanding of RA pathogenesis and may further help develop strategies for mucosal modulation of RA.

Shift in perspective: autoimmunity protecting against rheumatoid arthritis

An overview of autoantibodies in rheumatoid arthritis

Bridging autoantibodies and arthritis: the role of Fc receptors

Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis

Systemic inflammation and lymphocyte activation precede rheumatoid arthritis

From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis

A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis

The role of anti-citrullinated protein antibody in pathogenesis of RA

ACPA Mediates the Interplay Between Innate and Adaptive Immunity in Rheumatoid Arthritis.

Immune response to post-translationally modified proteins in rheumatoid arthritis: what makes it special?

Autoimmunity: Another Pathway Towards Arthritis.

Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis

Immmunopathogenesis of rheumatoid arthritis; induction of arthritogenic autoimmune responses by proinflammatory stimuli

Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss

Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies

Antibodies to Citrullinated Proteins: Molecular Interactions and Arthritogenicity

Individuals at risk of seropositive rheumatoid arthritis: the evolving story

Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis

Autoimmune priming, tissue attack and chronic inflammation - the three stages of rheumatoid arthritis.

Aberrant Activation of Immune and Non-Immune Cells Contributes to Joint Inflammation and Bone Degradation in Rheumatoid Arthritis

Bugs & us: the role of the gut in autoimmunity